IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 4844 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


A 12-week prospective randomized controlled comparative trial of vilazodone and sertraline in Indian patients with depression

Bathla Manish, Anjum Shazia

Year : 2020| Volume: 52| Issue : 1 | Page no: 10-15

   This article has been cited by
1 An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
N Simple Santi, Sashi Bhusan Biswal, Birendra Narayan Naik, Jyoti Prakash Sahoo, Bhabagrahi Rath
Cureus. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 Sexual dysfunction with major depressive disorder and antidepressant treatments: impact, assessment, and management
Joan R. Winter, Kimberly Curtis, Bo Hu, Anita H. Clayton
Expert Opinion on Drug Safety. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression
Pattath Narayanan Suresh Kumar, Rohith Suresh, Vikas Menon
Indian Journal of Psychological Medicine. 2022; : 0253717622
[Pubmed]  [Google Scholar] [DOI]
4 Vilazodone for Major Depression in Adults: Pharmacological Profile and an Updated Review for Clinical Practice
Mohit Chauhan, Rebecca Parry, William V Bobo
Neuropsychiatric Disease and Treatment. 2022; Volume 18: 1175
[Pubmed]  [Google Scholar] [DOI]
5 Mental depression: Relation to different disease status, newer treatments and its association with COVID-19 pandemic (Review)
Mohamed Abdel-Bakky, Elham Amin, Tarek Faris, Ahmed Abdellatif
Molecular Medicine Reports. 2021; 24(6)
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow